FDA Inspection 1019104 — University of Pittsburg Medical Center, Hillman Cancer Center
The FDA completed an inspection of University of Pittsburg Medical Center, Hillman Cancer Center on June 29, 2017 in Carlisle, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 29, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Carlisle, PA (United States)